Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label on the page header was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoved the general government funding operating status notice from the page. No study data, eligibility criteria, or contact information were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe two screenshots show only minor text edits and formatting changes on the Study Details page, with no changes to core content such as objectives, interventions, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 'Last Update Posted (Estimated)' label and adds update dates 2025-10-23 and 2025-10-24; earlier update dates 2025-08-12 and 2025-08-08 were removed.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference1%

- Check78 days agoChange DetectedUpdate to version v3.1.0 with removal of two specific medical terms (Acute lymphoblastic leukemia and Methylprednisolone Acetate) and no other substantive additions.SummaryDifference0.1%

Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.